This list is based on the watchlists of people on Stock Events who follow 9606.HK. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Duality Biotherapeutics, Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others. The company provides DB-1303/BNT323, a HER2 ADC candidate targeting cancers, including endometrial cancer1 and breast cancer2; DB-1311/BNT324, a B7-H3 ADC candidate targeting cancers, such as small-cell lung cancer3, castration-resistant prostate cancer4, esophageal squamous cell carcinoma5, and head and neck squamous cell carcinoma; and other clinical-stage ADCs. It has strategic partnerships with BioNTech SE to develop therapies to complement or replace chemotherapy; and BeiGene, Ltd. to develop and commercialize DB-1312, an in-house discovered B7-H4- targeted ADC. The company was incorporated in 2019 and is headquartered in Shanghai, China.
What is Duality Biotherapeutics stock price today?▼
The current price of 9606.HK is HK$292.6 HKD — it has increased by +0.41% in the past 24 hours. Watch Duality Biotherapeutics stock price performance more closely on the chart.
What is Duality Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Duality Biotherapeutics stocks are traded under the ticker 9606.HK.
Is Duality Biotherapeutics stock price growing?▼
9606.HK stock has fallen by -5.8% compared to the previous week, the month change is a +14.3% rise, over the last year Duality Biotherapeutics has showed a +41.08% increase.
What is Duality Biotherapeutics market cap?▼
Today Duality Biotherapeutics has the market capitalization of 25.76B
When is the next Duality Biotherapeutics earnings date?▼
Duality Biotherapeutics is going to release the next earnings report on August 26, 2026.
What is Duality Biotherapeutics revenue for the last year?▼
Duality Biotherapeutics revenue for the last year amounts to 1.35B HKD.
What is Duality Biotherapeutics net income for the last year?▼
9606.HK net income for the last year is -2.27B HKD.
In which sector is Duality Biotherapeutics located?▼
Duality Biotherapeutics operates in the Other sector.
When did Duality Biotherapeutics complete a stock split?▼
Duality Biotherapeutics has not had any recent stock splits.